Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950806 · ClinicalTrials.gov registry record · NA
The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01950806: Completed NA study, sponsored by Tufts University.
NCT01950806 is a NA study that has completed, run by Tufts University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01950806, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The objective of this randomized, controlled feeding study is to investigate the potential health benefits of a pecan-containing diet. The investigators hypothesize the chronic consumption of pecans will improve an array of biomarkers related to cardiovascular disease and type 2 diabetes risk, including indices of oxidative stress, antioxidant activity, inflammation, endothelial function, and insulin resistance when compared with a control diet that is absent nuts.
Interventions
- OTHER Pecan-containing diet
- OTHER Nut-free diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01950806 record still lists
NCT01950806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Pecan-containing diet is the first listed.
NCT01950806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01950806 about?
NCT01950806 is a clinical study titled "The Effect of Pecans on Biomarkers of Risk for Cardiovascular Disease and Diabetes". The objective of this randomized, controlled feeding study is to investigate the potential health benefits of a pecan-containing diet. The investigators hypothesize the chronic consumption of pecans will improve an array of biomarkers related to cardiovascular disease and type 2 diabetes risk, inclu...
What is the current status of trial NCT01950806?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-01. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01950806?
The interventions under investigation include: Pecan-containing diet (OTHER), Nut-free diet (OTHER).
Who is sponsoring clinical trial NCT01950806?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01950806's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia